467
edits
Diabetes: Difference between revisions
no edit summary
No edit summary |
No edit summary |
||
| Line 224: | Line 224: | ||
*Increased risk of Human gastrointestinal tract|gastrointestinal problems | *Increased risk of Human gastrointestinal tract|gastrointestinal problems | ||
*Contraindicated for people with moderate or severe kidney disease or heart failure because of risk of lactic acidosis | *Contraindicated for people with moderate or severe kidney disease or heart failure because of risk of lactic acidosis | ||
*Increased risk of Vitamin B12 deficiency<cite>63</cite> | *Increased risk of Vitamin B12 deficiency<cite>63</cite><cite>65</cite><cite>66</cite> | ||
*Less convenient dosing | *Less convenient dosing | ||
*Metallic taste<cite>63</cite> | *Metallic taste<cite>63</cite><cite>65</cite><cite>66</cite> | ||
|- | |- | ||
|Alpha-glucosidase inhibitor (acarbose, miglitol) | |Alpha-glucosidase inhibitor (acarbose, miglitol) | ||